AGOMAB THERAPEUTICS NV

AGMB · NASDAQ

Updated at 2026-10-15 08:52:30

$8.69-1.36%
Today's High
$9.08
Today’s Low
$8.51
AGOMAB THERAPEUTICS NV (AGMB) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$8.80
Previous Close
$8.69
Volume
57.69K
Market Cap
$433.87M
P/E Ratio
--
EPS
$-1.28

Previous Day Range

$8.51$9.08

52-Week Range

$7.97$17.82

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
BIOTECHNOLOGY
Headquarters
POSTHOFLEI 1/6, ANTWERP, BELGIUM, 2600
Country
BE
Listing Date
2026-02-06
Fiscal Year End
December
Shares Outstanding
49.25M
CIK
--
Website
agomab.com

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs. The company is headquartered in Antwerp, Belgium.

Financial Metrics

Revenue

2026-03-31

--

2025-12-31

$0

2025-09-30

$0

2024-12-31

$0

Operating Expenses

2026-03-31

$11.81M

2025-12-31

$16.52M

2025-09-30

$15.35M

2024-12-31

$11.81M

Net Income

2026-03-31

-$11.73M

2025-12-31

-$17.4M

2025-09-30

-$18.27M

2024-12-31

-$11.73M

Net Profit Margin

2026-03-31

--

2025-12-31

--

2025-09-30

--

2024-12-31

--

Earnings Per Share

2026-03-31

$-0.41

2025-12-31

--

2025-09-30

--

2024-12-31

--

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-03-31

-$11.79M

2025-12-31

-$17.62M

2025-09-30

-$18.04M

2024-12-31

-$11.79M

Effective Tax Rate

2026-03-31

-0.03%

2025-12-31

--

2025-09-30

--

2024-12-31

-0.03%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.